NRNeetu Rajpoot

Neetu Rajpoot

*This is an algorithmically generated author record based on publicly available information.

Neetu Rajpoot has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Explainable Machine Learning Using Taguchi-QbD Data for Digital Design Space Mapping of Pregabalin Extended-Release Tablets

    by Deepender, Tarandeep Singh Walia, Sreenath Sriram, Nabeel Ahmad, Sonal Solanki, Nikunj Solanki, Jyoti Maithani Kalra, Yamsani Shravan, Sreekanth Thota, Kapil Kalra, et al.

    This study applied explainable machine learning to published Taguchi-QbD data for pregabalin extended-release tablets to support formulation understanding and digital design space mapping. No new experimental batches were prepared; the analysis used formulation-response data from a previously developed pregabalin extended-release tablet system. A secondary data set containing 16 Taguchi formulations was prepared using six formulation and process variables: lipid material type, lipid quantity, hydrophilic matrix type, hydrophilic matrix quantity, filler type, and compression force. Hardness, friability, and dissolution at 1, 2, 4, and 8 h were selected as modeling responses. Ridge regression, random forest regression, extra trees regression, and Gaussian process regression were evaluated using leave-one-out cross-validation. Model-independent explainability was performed using permutation feature importance, partial dependence analysis, and surrogate decision-tree rules. A desirability-based virtual formulation screening approach was then used to identify high-desirability regions within the original experimental design limits. Dissolution at 2 h and 4 h showed the most useful cross-validated predictive performance, with mean absolute errors of 10.25% and 8.10%, respectively. Explainability analysis identified hydrophilic matrix quantity as the dominant variable controlling early and intermediate drug release, whereas lipid type and lipid quantity were more influential for tablet hardness and late-stage release behavior. Among the original Taguchi formulations, F15 showed the highest observed desirability, although it did not fully satisfy all dissolution criteria. Virtual screening identified high-desirability in silico candidates characterized mainly by high hydrophilic matrix loading and adequate lipid content. The published optimized formulation was positioned within a high-desirability AI-predicted region, supporting consistency between the explainable ML workflow and the original QbD optimization. These findings indicate that small-data explainable machine learning can complement QbD-based formulation analysis by extracting formulation rules and prioritizing design-space regions; however, AI-predicted candidates require experimental confirmation.

  • Open Access

    Machine Learning Modeling of D-Optimal Design Data for Metformin Hydrochloride Orally Disintegrating Tablets

    by Sanju, Suresh Yarlagadda, Vinay Kumar, Sreenath Sriram, Nabeel Ahmad, Sonal Solanki, Nikunj Solanki, Jyoti Maithani Kalra, Yamsani Shravan, Sreekanth Thota, et al.

    Metformin hydrochloride orally disintegrating tablets require an appropriate balance between mechanical strength and rapid disintegration, particularly because the drug is administered at a relatively high dose and has unfavorable taste characteristics. The present study applied machine learning to published D-optimal design data for metformin hydrochloride orally disintegrating tablets to evaluate whether formulation and process variables could predict powder-flow and tablet-performance responses. The dataset contained 30 experimental runs with four inputs: co-processed metformin hydrochloride ratio, co-processed excipient ratio, compression pressure, and excipient brand. Five responses were modeled separately: angle of repose, Hausner’s ratio, Carr’s index, hardness, and disintegration time. Polynomial Ridge Regression, Random Forest, Extra Trees, Gradient Boosting, Support Vector Regression, Gaussian Process Regression, and k-nearest neighbors were compared using leave-one-out cross-validation. Model performance was assessed using mean absolute error, root mean square error, and cross-validated R². Gaussian Process Regression was the best model for Hausner’s ratio, Carr’s index, hardness, and disintegration time, while Support Vector Regression performed best for angle of repose. Tablet hardness and disintegration time were predicted with the strongest performance, with R² values of 0.840 and 0.858, respectively. In contrast, angle of repose was weakly predicted, with an R² of 0.158. Permutation importance and partial dependence analysis indicated that compression pressure and excipient brand were the main contributors to tablet-level responses. The findings show that machine learning can support interpretation of D-optimal formulation data, especially for tablet-performance attributes, while predictions remain limited by dataset size and absence of new external validation.


  • Open Access

    Simultaneous Estimation of Ciprofloxacin and Tinidazole by U.V Spectrophotometer using a Hydrotropic Solubilization Technique

    by Km. Babita, Kapil Kalra, Neetu Rajpoot, Poonam Joshi, Vandana Pokhriyal

    Advanced, easy and accurate UV spectroscopy technique (I & II) was developed for estimation of Ciprofloxacin and Tinidazole in bulk and tablet dosage form and validated using hydrotropic solubilization techniques. In Method I we focused on solving the simultaneous equation on the basis of absorbance measurement at 270nm and 320nm wavelength of Ciprofloxacin and Tinidazole individually in 2M urea solution which results in enhancement of solubility of CPH and TNZ to about 15 folds as compared to distilled water.Strategy II is lay out idea of Q-analysis in which absorbance was estimated at 288nm (iso-absorptive point) 270nm (λmax of CPH) in 2M urea. Ciprofloxacin and Tinidazole display linearity at chose frequencies and comply with Beer's regulation in the focus scope of 0.2-1.2μg/mL and 10 to 60μg/mL separately. Recovery reads up for CPS and TNZ were completed and rate recuperation of the medications gotten in the scope of 99.2 - 99.6% (Method A) and 98.0-100.8% (Method B) affirming the exactness of the proposed strategy. Both the techniques showed great reproducibility and recuperation with %RSD less than 2. Factual approval of the information shows that the proposed strategies can be effectively applied for the standard examination of medications in business tablets.